WARREN C FISKUS to Cyclin-Dependent Kinase Inhibitor p21
This is a "connection" page, showing publications WARREN C FISKUS has written about Cyclin-Dependent Kinase Inhibitor p21.
Connection Strength
0.040
-
A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer. Breast Cancer Res Treat. 2014 Jul; 146(1):145-52.
Score: 0.026
-
Activity of suberoylanilide hydroxamic Acid against human breast cancer cells with amplification of her-2. Clin Cancer Res. 2005 Sep 01; 11(17):6382-9.
Score: 0.014